Mechanism: Rapamycin inhibits mTORC1, creating a rigid epigenetic state that promotes longevity in stable, low-stress environments but impairs cellular flexibility under acute stress. Readout: Readout: Lifespan increases by 25% under low stress but decreases by 15% under high stress, correlating with reduced cellular flexibility.
Hypothesis
Rapamycin‑mediated mTORC1 inhibition creates a scarcity‑mimetic epigenetic program that extends lifespan only when the external environment remains predictably low‑stress; under fluctuating or novel stressors this program reduces physiological flexibility and shortens survival.
Mechanistic Basis
mTORC1 suppression lowers S6K activity and 4E‑BP phosphorylation, decreasing global translation and favoring transcription of ATF4‑driven stress genes rapamycin induces autophagy and ATF4-mediated stress responses, mimicking hormesis rather than repairing damage. This shift conserves resources but also remodels chromatin via reduced acetyl‑CoA production, promoting histone deacetylation at promoters of growth‑related genes. Concurrently, lowered HIF‑1α translation diminishes hypoxia‑inducible signaling, attenuating the ability to mount rapid glycolytic bursts during acute oxygen deprivation. The net effect is a cellular state resembling dauer or diapause: high maintenance, low proliferation, and a rigid epigenome that resists re‑programming when conditions change.
Testable Predictions
- Organisms treated with rapamycin will show increased lifespan under constant low‑nutrient, low‑temperature conditions but decreased lifespan when exposed to intermittent high‑nutrient pulses or acute heat shock compared with untreated controls.
- Rapamycin‑treated animals will exhibit reduced inducible HSP70 expression and slower recovery from protein‑aggregation stress despite higher basal autophagy levels.
- Chromatin immunoprecipitation sequencing will reveal decreased H3K27ac at ribosomal protein gene promoters and increased H3K9me3 at stress‑response loci after chronic rapamycin exposure, indicating a locked‑down epigenome.
Experimental Design
- Use C. elegans cohorts split into four groups: control, rapamycin continuous, rapamycin intermittent (drug withdrawn every 5 days), and rapamycin plus periodic heat shock (30 min at 35 °C every 3 days). Monitor survival curves, brood size, and motility.
- Measure basal and induced autophagy (LG‑1::GFP puncta) and HSP‑70::GFP reporter activity after a 2‑hour 37 °C heat shock.
- Perform ATAC‑seq and H3K27ac ChIP‑seq on young adult worms from each group to assess chromatin accessibility and acetylation at metabolic and stress‑gene promoters.
- In parallel, treat mouse embryonic fibroblasts with rapamycin for 2 weeks, then challenge with palmitate‑induced ER stress; assess CHOP expression and cell viability.
Potential Implications
If validated, the hypothesis reframes rapamycin not as a universal anti‑aging drug but as a context‑dependent stress mimetic whose benefits hinge on environmental stability. It suggests that longevity interventions should be paired with strategies that preserve epigenomic plasticity or that intermittent dosing may avoid locking cells into a maladaptive low‑flexibility state.
Comments
Sign in to comment.